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Abstract
Retinal ischemia/reperfusion injury is a common feature of various retinal diseases such as
glaucoma and diabetic retinopathy. Lutein, a potent anti-oxidant, is used to improve visual
function in patients with age-related macular degeneration (AMD). Lutein attenuates apo-
ptosis, oxidative stress and inflammation in animal models of acute retinal ischemia/hyp-
oxia. Here, we further show that lutein improved Műller cell viability and enhanced cell
survival upon hypoxia-induced cell death through regulation of intrinsic apoptotic pathway.
Moreover, autophagy was activated upon treatment of cobalt (II) chloride, indicating that
hypoxic injury not only triggered apoptosis but also autophagy in our in vitro model. Most
importantly, we report for the first time that lutein treatment suppressed autophagosome for-
mation after hypoxic insult and lutein administration could inhibit autophagic event after acti-
vation of autophagy by a pharmacological approach (rapamycin). Taken together, lutein
may have a beneficial role in enhancing glial cell survival after hypoxic injury through regulat-
ing both apoptosis and autophagy.
Introduction
Ocular diseases associated with retinal ischemia/reperfusion (I/R) injury lead to irreversible
retinal cell death. In rodent models of retinal I/R injury induced by blockade of internal
carotid artery, a remarkable cell loss was found in both ganglion cell layer (GCL) and inner
nuclear layer (INL) in the retina [1]. Another study using an animal model of I/R injury
induced by elevating the intraocular pressure also demonstrated an increase of apoptotic
nuclei in INL [2].
Autophagy is an evolutionary conserved mechanism that allows the cell to degrade dam-
aged proteins and intracellular organelles, maintaining cell homeostasis against nutrient depri-
vation and cellular stress [3]. Autophagy appears to be protective at the early onset of stress
condition but can lead to cell death when excessively up-regulated. Produit-Zengaffinen et al
and Piras et al reported that autophagy was triggered after I/R injury and resulted in further
damage in retinal neurons [4,5].
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Lutein is a member of xanthophyll family of carotenoids and it can be found in some dark
leafy vegetables such as kale and spinach [6,7]. Lutein cannot be synthesized by the human
body; therefore, it has to be obtained from the daily diet. Lutein consists of two hydroxyl
groups, making it reacting more strongly with singlet oxygen than other carotenoids [8,9].
Lutein is also an efficient pigment for absorbing high energy blue light and protects photore-
ceptors from phototoxicity [10,11]; therefore lutein is known as a potent anti-oxidant and oxy-
gen free radical scavenger. Clinically, lutein has been found to improve visual function and
macular pigment optical density in patients with age-related macular degeneration (AMD)
[12–14]. In addition, lutein has been shown to be neuroprotective in different retinal disease
models including endotoxin-induced uveitis (EIU), light-induced retinal degeneration and
retinal ischemia/reperfusion injury [1,15,16].
Műller cells are the principle glia of retina and they protect retinal neurons from excitotoxic
damage as well as reactive oxygen species (ROS) induced by ischemia [17]. Műller cell gliosis
responding to I/R injury results in retinal cell death [18]. We have previously shown that lutein
administration protects retinal neurons from I/R injury in vivo and from oxidative stress in
vitro [1,19]. In vitro hypoxia can be achieved by chemical-induced hypoxia or by oxygen-glu-
cose deprivation (OGD) [20]. Cobalt (II) chloride (CoCl2), a common reagent to mimic the
hypoxic/ischemic condition, induces the generation of reactive oxygen species (ROS) and in
turn increases oxidative stress, resulting in cell death. It has been reported that ROS was
induced in retinal ischemia and eventually led to retinal cell death [17]. We previously used
CoCl2 to induce chemical hypoxia and demonstrated that lutein treatment attenuated the
release of pro-inflammatory cytokines in a cultured rat Műller cell line (rMC-1) [21]. In the
present study, we aim to further evaluate the anti-apoptotic effects of lutein in rMC-1 cells
against CoCl2-induced hypoxic injury. In addition, as autophagy and apoptosis have been
shown to be co-activated upon CoCl2 insult [22], we hypothesize lutein exerts a protective role
in hypoxia-induced autophagy in rMC-1 cells.
Materials and Methods
Reagents
Lutein, cobalt (II) chloride, ammonium chloride, 3-Methyladenine (3-MA), and dimethyl sulf-
oxide (DMSO) were purchased from Sigma-Aldrich (St. Louis, MO). Rapamycin and Chloro-
quine were purchased from Enzo Life sciences. Lutein was dissolved in 100% DMSO and a
stock solution (10mg/ml) was prepared and kept at -80˚C until use. Lutein stock solution was
further diluted in 0.01% DMSO as the working solution. Cobalt (II) chloride (10mM), ammo-
nium chloride (1M), 3-MA (67mM), and chloroquine (60mM) were dissolved in water, respec-
tively. Rapamycin was dissolved in DMSO at 500μM.
Cell culture
An immortalized rat Műller cell (rMC-1) was routinely maintained in Dulbecco’s modified
Eagle’s medium (Gibco, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS,
Hyclone, Logan UT, USA), 100U/ml penicillin and 100ug/ml streptomycin (Gibco) [23]. Cells
were grown in a humidified incubator of 95% air and 5% CO2 at 37˚C and passaged when
reached 80% confluent. Chemical-induced hypoxia was induced using cobalt (II) chloride
(CoCl2) as described previously [21]. Briefly, rMC-1 cells were prepared in 6-well plates at a
density of 2 x 105 cells per well in DMEM and incubated 24 hours before treatment. Next, the
cells were starved in DMEM with 1%FBS for 4 hours before inducing hypoxia. For dose depen-
dent study, CoCl2 (300μM) was used to induce chemical hypoxia together with different doses
of lutein (2.5, 5, 10 and 20 μM) or vehicle (0.01% DMSO) for 24 hours. For time dependent
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study, CoCl2 (300μM) was used to induce chemical hypoxia together with lutein (20 μM) or
vehicle (0.01% DMSO) for designated time points. To examine the involvement of autophagy
in CoCl2 -induced cell death, rMC-1 cells was treated with 3-MA (1mM) for 2 hours before
CoCl2 treatment for 24 hours. To access the autophagic flux, rMC-1 cells were incubated with
CoCl2 and ammonium chloride (NH4Cl) for 24 hours. To induce the mTOR-mediated autop-
hagy, rMC-1 cells were exposed to rapamycin and chloroquine for 16 hours.
Cell Viability Assay
Cell viability was examined using Celltiter 96 Aqueous Non-radioactive Cell Proliferation Assay
(Promega, Madison, WT) according to the manufacturer’s protocol. Briefly, rMC-1 cells were
seeded into 96-well plates as previously described [21]. Next, cells were treated as described
above for designated time periods. After washes by 0.01M PBS, a mixture of 3-(4,5-dimethylthia-
zol-2yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) and phenazine
methosulfate (PMS) was added to the wells and incubated for 3 hours at 37˚C. Absorbance was
measured with a microplate reader (ELX 800; Biotek Instruments, Winooski, VT) at 490nm. All
results were obtained from five individual experiments in triplicates.
Lactate dehydrogenase (LDH) cytotoxicity assay
CoCl2-induced cytotoxicity in rMC-1 cells leading to leakage of cytoplasmic enzyme lactate
dehydrogenase (LDH) into culture medium was measured by Cytotoxicity Detection Kit
(Roche) according to the manufacture’s instruction. CoCl2-induced hypoxia in rMC-1 cells
was performed as described above. After treatments, both cell culture medium and cell lysate
were incubated with the substrate containing Diaphorase/NAD+ as well as INT/sodium lactate
for 15 minutes. Absorbance of LDH activities were measured at 490nm. Amount of LDH
released from apoptotic cells was calculated as percentage of the total LDH activities. The
results were obtained from five individual experiments with duplicate samples.
Terminal Deoxynucleotidyl Transferase dUTP Nick End Labeling
(TUNEL) assay
In Situ detection of apoptotic cells were performed using a DeadEndTM Fluorometric TUNEL
System (Promega, Madison, WT). The assay was performed in accordance with the manufactur-
er’s protocol. Briefly, rMC-1 cells were grown on chamber slides and treatments were given as
mentioned above. The cells were then fixed with 4% paraformaldehyde for 15 minutes at 4˚C.
After permeabilization with 0.1% Triton X-100 for 2 minutes, cells were incubated with the reac-
tion mix containing terminal deoxynucleotidyl transferase (TdT) and nucleotides for 1 hour at
37˚C. 4’,6-diamidino-2-phenlindole (DAPI) was used to stain the nuclei. Five nonoverlapping
fields in each well were captured using a light microscope (Eclipse 80i Nikon, Tokyo, Japan)
equipped with a digital camera (Diagnostic Instruments, Inc., Sterling Heights, MI). More than
250 cells in each field were counted using Image J software (National Institute of Mental Health,
Bethesda, MD). Cells with TUNEL labeling co-localized with DAPI staining were counted as
TUNEL-positive. The results were expressed as percentage of TUNEL-positive cells over the
total number of cells counted from five individual experiments with duplicate samples.
Western blot analysis
Whole cell lysates was prepared by addition of lysis buffer (50mM Tris PH 7.4, 150mM NaCl,
1% Triton X-100, 0.1% SDS, 1% Sodium deoxycholate). 10μg of protein lysate was separated
by SDS-PAGE and then transferred to polyvinylidene difluoride membranes. After blocking
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with 5% non-fat milk, the membranes were incubated with primary antibodies, β-actin
(1:5000; Chemicon, Temecula, CA), Bcl-2 (1:1000; Santa Cruz Biotechnology, Santa Cruz,
CA), Bcl-XL (1:1000; Cell Signaling Technology, Beverly, MA), Bax (1:1000; Cell Signaling
Technology, Beverly, MA), Cleaved Caspase 3 (1:1000; Cell Signaling Technology, Beverly,
MA), LC3 (1:1000; Cell Signaling Technology, Beverly, MA), P-p70S6K (1:1000; Cell Signaling
Technology, Beverly, MA), p70S6K (1:1000; Cell Signaling Technology, Beverly, MA), p-
AMPK (1:1000; Cell Signaling Technology, Beverly, MA), AMPK (1:1000; Cell Signaling Tech-
nology, Beverly, MA), p-mTOR (1:1000; Cell Signaling Technology, Beverly, MA), mTOR
(1:1000; Cell Signaling Technology, Beverly, MA), p-ULK1(Ser757) (1:1000; Cell Signaling
Technology, Beverly, MA) overnight at 4˚C. After incubation with secondary antibody, signals
were detected by ECL (Amersham Pharmacia Biotech, Arlington Height, IL) on a X-ray film,
which was scanned and quantified using Image J software (National Institute of Mental Health
Bethesda). Five independent experiments with duplicate samples were performed.
Analysis of CoCl2-induced autophagy in rMC-1 cells
Assessment of autophagic activity in rMC-1 cells was performed using Cyto-ID1 Autophagy
Detection kit (Enzo, Life Science). In brief, cells were grown on a chamber slide and treated
with CoCl2 (300μM) as well as Lutein (20μM) for 24 hours. Cells co-treated with 0.5μM rapa-
mycin and 120μM chloroquine for 16 hours were used as the positive control to induce autop-
hagy and to identify the autophagic vesicles in rMC-1 cells. After washes by assay buffer, cells
were incubated with Cyto-ID1 Green Detection Reagent for 45 minutes at 37˚C. Hoechst
33342 was used as a nuclei counterstain. Eight non-overlapping fields were photographed in
each group using a light microscope (Eclipse 80i Nikon, Tokyo, Japan) equipped with a digital
camera (Diagnostic Instruments, Inc., Sterling Heights, MI) and analyzed with Image J soft-
ware (National Institute of Mental Health, Bethesda, MD). At least three independent experi-
ments were performed.
Immunocytochemical analysis of autophagosomal-associated LC3
expression in rMC-1 cells
Assessment of autophagosomes in rMC-1 cells was performed by immunocytochemistry of
LC3 expression. Briefly, cells were grown on a chamber slide and treated with CoCl2 (300μM)
and NH4Cl (20mM) as well as Lutein (20μM) for 24 hours. The cells were then fixed with ice-
cold methanol for 15 minutes at -20˚C. After washes by PBS, cells were permeabilized with
0.3% Triton X-100 for 2 minutes. After blocking with 5% serum for 1 hour, the cells were incu-
bated with LC3 antibody (1:400; Cell Signaling Technology, Beverly, MA) overnight at 4˚C.
After incubation with anti-Rabbit IgG FITC-conjugated secondary antibody, cell nuclei were
counterstained by 4’,6-diamidino-2-phenlindole (DAPI). Eight nonoverlapping fields in each
well were captured using a light microscope (Eclipse 80i Nikon, Tokyo, Japan) equipped with
a digital camera (Diagnostic Instruments, Inc., Sterling Heights, MI) and analyze with Image
J software (National Institute of Mental Health, Bethesda, MD). At least three independent
experiments were performed.
Statistical Analysis
Data were presented as mean ± SEM and analyzed using Prism v4.0. (GraphPad software Inc.,
San Diego, CA). ANOVA followed by Bonferroni multiple comparison tests was used for all
data analysis. P value less than 0.05 was set as statistically significant.
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Results
Lutein ameliorated cobalt (II) chloride (CoCl2)-induced hypoxic cell death
in cultured rat Műller cells (rMC-1)
To mimic the hypoxic/ischemic condition, 300μM of CoCl2 was used to induce chemical hyp-
oxia in rMC-1 cells [19,21]. The morphology of vehicle-treated rMC-1 cells started to change 6
hours after the CoCl2 treatment when compared with that in the normal control (Fig 1E and
1F). Cells became round in shape and cytoplasmic vacuoles were observed (Fig 1E and 1F). On
the other hand, the morphology of lutein-treated cells remained similar to that in the normal
control despite the exposure to CoCl2 for 24 hours (Fig 1I). rMC-1 cells treated with lutein
alone (20 μM) did not show any significant difference in cell viability when compared with
normal control in all time periods tested. On the other hand, viability of vehicle-treated rMC-1
cells started to decline at 6 hours after CoCl2 treatment; there was approximately 50% loss of
cell viability after hypoxic challenge for 24 hours (Fig 1J). Lutein-treated rMC-1 cells were also
affected upon CoCl2-induced injury, resulting in around 20% reduction of cell viability. How-
ever, viability of lutein-treated rMC-1 cells were not further affected upon prolonged CoCl2
treatment (Fig 1J). CoCl2-induced cytotoxicity in rMC-1 cells also led to release of lactate
dehydrogenase (LDH) at 24 hours after hypoxic challenge; yet, LDH release was attenuated in
lutein-treated rMC-1 cells (Fig 1K). To further assess if CoCl2-induced cytotoxicity was associ-
ated with apoptosis, TUNEL staining was performed to identify the apoptotic nuclei in rMC-1
cells (Fig 2A) and their numbers were counted. Percentage of apoptotic nuclei started to ele-
vate at 2 hours after incubation with CoCl2 and continued to rise until 24 hours in vehicle-
treated rMC-1 cells, indicating that CoCl2 induced apoptosis-related cell death in a time-
dependent manner (Fig 2B). The percentage of apoptotic nuclei was decreased after lutein
treatment for 24 hours when compared with the vehicle-treated rMC-1 cells. This finding is
consistent with the cell viability assay that lutein rescued rMC-1 cells from CoCl2-induced
hypoxia at 24 hours.
Lutein protected rMC-1 cells from hypoxic-induced cell death by altering
expression of apoptosis-associated proteins
The role of Bcl-2 family proteins in CoCl2-induced apoptosis and lutein-mediated protection
was studied. Exposure of rMC-1 cells to CoCl2 significantly down-regulated the expression of
two anti-apoptotic proteins, Bcl-2 and Bcl-XL when compared with normal control, resulting in
more than 50% reduction in their protein levels at 24 hours (Fig 3A and 3B; Fig 4A and 4B).
However, expression of a pro-apoptotic protein, Bax, was shown a trend of increase upon CoCl2
treatment (Figs 3C and 4C). The ratio of Bax to Bcl-2 protein expression and cleaved caspase 3
were significantly up-regulated after incubation with CoCl2 for 24 hours in vehicle-treated cells
(Fig 3D and 3E; Fig 4D and 4E). Protein level of Bcl-2 but not Bcl-XL was enhanced by 20 μM of
lutein at 24 hours while that of Bax remained unaffected (Fig 3A, 3B and 3C; Fig 4A, 4B and 4C).
Furthermore, Bax/Bcl-2 ratio as well as cleaved caspase 3 was remarkably attenuated by 20μM of
lutein upon CoCl2-induced hypoxia for 24 hours (Fig 3D and 3E; Fig 4D and 4E). Together,
these data suggested that the Bcl-2 protein family was involved in lutein-mediated protection
against CoCl2-induced apoptosis in rMC-1 cells.
Lutein was involved in anti-autophagic mechanism in CoCl2 -induced
autophagy in rMC-1 cells
It has been reported that hypoxia- inducible factor 1 α (HIF-1α) was activated by CoCl2 and
triggered hypoxic cell death and autophagy [22,24]. We therefore further investigated whether
Lutein-Mediated Protection in Retinal Műller Cell
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Fig 1. Lutein rescued rMC-1 cells from CoCl2-induced hypoxic injury. rMC-1 cells were exposed to CoCl2
(300μM) with or without lutein for various periods. Representative photographs of rMC-1 cells (A-C) normal control,
(D-F) hypoxia with vehicle (0.01% DMSO), (G-I) hypoxia with lutein (20μM). (J) Percentage of cell viability.
Treatment of lutein only without hypoxia did not affect the viability when compared with the normal control. Lutein-
treated rMC-1 cells showed higher cell viability when compared with the vehicle-treated group at 24 hours. (K)
Percentage of lactate dehydrogenase (LDH) release from damaged cells. Lutein attenuated LDH release after
CoCl2-induced injury when compared with that in vehicle-treated group at 24 hours. n = 5 in each group. **P< 0.01,
***P<0.001 versus normal control group; #P< 0.05, ##P<0.01 versus vehicle-treated group. Scale bar, 100 μm.
doi:10.1371/journal.pone.0167828.g001
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CoCl2 induced autophagy and caused the loss of viability in rMC-1 cells. rMC-1 cells were
treated with 3-Methyladenine (3-MA), a selective autophagic inhibitor through suppressing
the activity of class III PI3K (an autophagic initiator) and inhibiting the early stage of autopha-
gosomal formation [25] before CoCl2 treatment for 24 hours. Viability of 3-MA pre-treated
cells was higher when compared with the vehicle control upon hypoxic injury while 3-MA
treatment only without hypoxia did not cause any significant difference in cell viability, indi-
cating CoCl2-induced autophagy contributed to hypoxic cell death in rMC-1 cells (S1 Fig). To
further monitor activation of autophagy, immunofluorescence analysis of the autophagosomes
and immunoblotting of microtubule-associated protein light chain 3 (LC3) were performed
[26]. LC3 comprises of two forms, the cytosolic LC3I and the lipidated LC3II. During onset of
autophagy, cytosolic LC3I is modified into the LC3II and localized on the double-membrane
of autophagosome. Thus, levels of LC3II are closely associated with abundance of autophago-
some [27]. In our experiments, protein expression of LC3II was determined after CoCl2 treat-
ment; it was activated at 2 hours after hypoxic injury and increased gradually until 24 hours
(Fig 5B). Yet, this was reversed by the application of 20μM lutein at 24 hours (Fig 5A and 5B),
indicating that lutein administration was able to attenuate the autophagic event upon CoCl2
treatment. Next, we examined autophagosome formation after 24 hours of CoCl2 exposure.
Immunofluorescence analysis revealed that green punctate vacuoles were observed at the
Fig 2. Number of apoptotic nuclei was attenuated in lutein-treated cells. Apoptotic nuclei were revealed by TUNEL assay after CoCl2 treatment at
different time points. (A) Representative images of TUNEL-positive nuclei (green) and DAPI-stained nuclei (blue) in rMC-1 cells. (B) Quantification of
TUNEL-positive cells. n = 5 in each group. Lutein administration significantly reduced the number of TUNEL-stained nuclei. Scale bar, 100 μm. *P<0.05,
**P< 0.01, ***P<0.001 versus normal control group; #P< 0.05 versus vehicle-treated group.
doi:10.1371/journal.pone.0167828.g002
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perinuclear region of the cells, indicating the presence of CoCl2-induced autophagy in rMC-1
cells (Fig 5C). This observation is consistent with the green-fluorescence labeled vacuoles as
shown in the positive control cells, which were co-treated with rapamycin and chloroquine to
induce autophagy (Fig 5C positive control). Lutein-treated rMC-1 cells, however, exhibited a
lower percentage of green-labeled vacuoles comparable to those observed in the normal con-
trol (Fig 5D). The decreased number of autophagsomal related vacuoles is in agreement with
the attenuated LC3II expression upon lutein administration. Accordingly, these data illus-
trated that CoCl2 induced autophagy as demonstrated by increasing LC3II expression and
autophagosome formation and these can be reversed by 20μM of lutein for 24 hours.
Lutein attenuated autophagosomes formation through regulating mTOR-
mediated pathway
Up-regulation of the autophagic marker by hypoxic injury can be due to either the increase of
autophagic flux or reduction of autolysosome degradation. Treatment with lysosomotropic agent
ammonium chloride (NH4Cl) in rMC-1 cells resulted in an increased protein expression of
LC3II, suggesting the blockade of autophagosome-lysosome fusion led to accumulation of autop-
hagosomes (Fig 6A, lane 2). When cells were co-treated with CoCl2 and NH4Cl for 24 hours,
LC3II expression was further elevated when compared with cells treated with CoCl2 alone (Fig
6A, lane 4). These data depicted that increased level of LC3II by CoCl2 is due to the enhancement
of autophagic flux rather than reduced clearance of autophagosome. Furthermore, co-treatment
of CoCl2 and NH4Cl for 24 hours showed an accumulation of punctate form of LC3 in rMC-1
cells (Fig 6B). To further investigate whether lutein is involved in attenuation the flux of autopha-
gosome formation, rMC-1 cells were treated with lutein together with NH4Cl and CoCl2 for 24
hours. LC3II expression as well as the percentage of LC3 punctate cells was significantly
decreased when compared with those without lutein treatment, suggesting that lutein reduced
autophagosomal flux in CoCl2-induced autophagy in rMC-1 cells (Fig 6A lane 5 and 6C).
Previous study reported that treatment of CoCl2 triggered an inhibition of mTOR pathway,
leading to autophagy in cardiomyoblasts [22]. To examine the involvement of mTOR-ass-
coiated pathway upon CoCl2-induced hypoxia, protein expression of phosphorylated AMP-
activated protein kinase (AMPK) which is a key energy sensor and functions as a negative reg-
ulator to mTOR was detected [28]. Phosphorylation of AMPK was remarkably up-regulated
upon CoCl2 treatment for 24 hours, suggesting that AMPK phosphorylation was triggered
upon hypoxia in rMC-1 cells (Fig 7A). Furthermore, activation of AMPK caused by CoCl2
treatment for 24 hours led to suppression of the phosphorylation of mTOR, p70S6K and
ULK1 (Ser757), strengthening the notion that inhibition of mTOR pathway was induced upon
CoCl2 treatment (Fig 7B, 7C and 7D). However, phosphorylation activities of both mTOR and
p70S6K were restored in lutein-treated cells (Fig 7B and 7D), depicting that mTOR pathway is
a possible pathway in lutein-mediated anti-autophagic effect. To further validate this finding,
rMC-1 cells were treated with rapamycin, which has been used to inhibit mTOR and induce
autophagy [26]. Activation of rapamycin-induced autophagy was determined by protein
Fig 3. Anti-apoptotic effects of lutein in rMC-1 cells upon CoCl2-induced hypoxia. rMC-1 cells were
exposed to CoCl2 (300μM) with various concentration of lutein for 24 hours. (A-D) Protein levels of different
apoptotic-related proteins including Bcl-2, Bcl-XL, Bax, and cleaved caspase 3 were measured by Western
blotting (normalized by β-actin) and quantified by densitometry. 20μM of Lutein was able to up-regulate
protein expression of Bcl-2 and protein level of cleaved caspase 3 was inhibited by both 10μM and 20μM of
lutein. (E) Densitometry analysis of ratio of Bax and Bcl-2 protein expression with different concentration of
lutein. Lutein improved rMC-1 cell survival by decreasing Bax/Bcl-2 ratio. n = 5 in each group. *P<0.05,
***P<0.001 versus normal control group; #P< 0.05, ##P<0.01 versus vehicle-treated group. N, Normal Control;
Veh, Vehicle (0.01% DMSO).
doi:10.1371/journal.pone.0167828.g003
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Fig 4. The length of lutein treatment in rMC-1 cells upon CoCl2-induced hypoxia. rMC-1 cells were exposed to
CoCl2 (300μM) with or without lutein (20μM) for different periods of time. (A-D) Protein levels of different apoptotic-
related proteins including Bcl-2, Bcl-XL, Bax, and cleaved caspase 3 were measured by Western blotting (normalized
by β-actin) and quantified by densitometry. Lutein treatment was able to rescue cells upon CoCl2-induced cell death
by up-regulating protein expression of Bcl-2 and suppressing cleaved caspase 3 at 24 hours. (E) Densitometry
analysis of ratio of Bax and Bcl-2 protein expression at different time points. Lutein improved rMC-1 cell survival by
decreasing Bax/Bcl-2 ratio at 24 hours. n = 5 in each group. *P<0.05, **P< 0.01, ***P<0.001 versus normal control
group; #P< 0.05, ###P<0.001 versus vehicle-treated group.
doi:10.1371/journal.pone.0167828.g004
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expression of LC3II. As shown in Fig 7E, incubation with rapamycin slightly up-regulated
LC3II expression. To prevent lysosomal degradation of LC3II in rapamycin-treated cells, cells
were treated with chloroquine to impair the LC3II protein turnover in the autolysosome.
Accumulation of autophagosomes was found in cells concomitantly treated with rapamycin
and chloroquine, as measured by the autophagic vacuoles formation by immunofluorescence
analysis and LC3II expression by Western blotting (Fig 5C positive control and Fig 7E, lane 6).
When rMC-1 cells were exposed to both rapamycin and chloroquine in the presence of lutein,
LC3II expression was remarkably attenuated to nearly the basal level of chloroquine-induced
LC3II (Fig 7E, lane 7). Together, these results suggest that lutein attenuates autophagic flux
from the mTOR-mediated autophagy in rMC-1 cells.
Fig 5. Lutein protected rMC-1 cells from CoCl2-induced autophagy. Western blot analysis of expression of an autophagic marker, LC3II, along with
the densitometric quantification (normalized by β-actin). (A) rMC-1 cells were exposed to CoCl2 (300μM) together with various concentration of lutein for 24
hours. LC3II expression was up-regulated upon CoCl2-induced hypoxia and attenuated by 20μM of lutein. (B) Expression of LC3II was up-regulated 2
hours after CoCl2 treatment and continued to increase in the remaining time points. Lutein was able to attenuate LC3II expression at 24 hours after hypoxic
challenge. (C) Autophagosome formation was monitored in rMC-1 cells 24 hours after CoCl2 treatment. Both normal control and treated cells were stained
with Cyto-ID® green dye and Hoechst 33342. Representative fluorescence microscopy images exhibited a decreased number of green fluorescence-
labeled autophagosomes in lutein-treated cells when compared with that in vehicle-treated cells. Rapamycin and chloroquine co-treatment in rMC-1 cells
were used as the positive control to identify the presence of autophagosome in the cells. (D) Quantification of Cyto-ID® green positive cells. Data was
presented as the percentage of Cyto-ID® green positive cells over the total number of cells counted. n = 4 in each group. **P< 0.01, ***P<0.001 versus
normal control group; #P<0.05, ##P<0.01 versus vehicle-treated group. Scale bar, 50 μm.
doi:10.1371/journal.pone.0167828.g005
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Discussion
Retinal ischemia/reperfusion (I/R) injury has been associated with different ocular diseases
such as diabetic retinopathy leading to irreversible neuronal death. Lutein belongs to the fam-
ily of xanthophylls and is known as a potent anti-oxidant. It protects the macula from the dam-
age of high energy blue light [12]. Our previous studies demonstrated the neuroprotective
effects of lutein in the retinal ischemic animal model [1,21,29]. We found that lutein protected
retinal neuron and attenuated Műller cell gliosis from I/R injury by its anti-oxidative and anti-
inflammatory properties [1,21]. Moreover, lutein could improve the viability of retinal neu-
rons from CoCl2-induced hypoxia in vitro [19] while the protective effects of lutein were also
observed in other in vitro models [30–32]. In the present study, lutein increased cell viability
and decreased LDH release after CoCl2 treatment. Lutein also attenuated the number of
TUNEL positive cells upon hypoxia, in agreement with our previous study that lutein reduced
apoptotic nuclei after retinal I/R injury [1].
CoCl2 have been commonly used in vitro to mimic the hypoxic/ischemic condition. It
induces reactive oxygen species (ROS) generation and leads to cell death. It has been reported
that ROS was induced by retinal ischemia and resulted in retinal cell death [17]. Although the
CoCl2 model only partly mimics the hypoxic condition, our earlier study clearly showed the
protective effects of lutein in Műller cells in vitro [21]. Another hypoxic model that is also com-
monly used is the oxygen-glucose deprivation (OGD), achieved by culturing cells in glucose-
free medium under low oxygen environment [20].
Several studies depicted that CoCl2 could alter protein expression of Bcl-2 family [33] and
trigger caspase-cascade apoptosis [34]. In our study, CoCl2 treatment suppressed the expres-
sion of anti-apoptotic proteins Bcl-2 and Bcl-XL. Although the expression of pro-apoptotic
protein Bax remained unaffected, there have been an increase of Bax/Bcl-2 ratio, an indicator
of intrinsic apoptotic pathway [35], followed by activation of cleaved caspase 3, suggesting that
CoCl2-induced hypoxia triggered this pathway. Our previous findings demonstrated that
20μM of lutein effectively suppressed the release of pro-inflammatory factors upon CoCl2-
induced hypoxic challenge in rMC-1 cells [21]. In the present study, we showed that treatment
of 20μM of lutein also enhanced Bcl-2 protein expression and abrogated Bax/Bcl-2 ratio after
24 hours of hypoxic injury. More importantly, lutein attenuated cleavage of caspase 3, consis-
tent with our previous finding using an animal model of retinal detachment [36], further
strengthening the notion that lutein mediated cytoprotection through regulating the cascade
of caspase-associated pathway.
The beneficial or detrimental effects of autophagy in ischemic injury remain controversial.
However, activation of autophagy in ganglion cell layer after retinal I/R injury has been docu-
mented differently, leading to ganglion cell death [4,37]. Most importantly, there is increasing
evidence that inhibition of autophagy is protective in various in vivo I/R models [38–40].
Moreover, several in vitro studies also demonstrated that suppression of both apoptosis and
autophagy enhanced cell survival [22,41]. Apart from apoptosis, CoCl2-induced hypoxia also
Fig 6. Lutein protected rMC-1 cells from CoCl2 –induced autophagy through reduction of autophagic
flux. rMC-1 cells were treated with CoCl2 in the presence or absence of an autophagic flux inhibitor,
ammonium chloride (NH4Cl), for 24 hours. (A) Western blotting and the densitometric quantification revealed
that LC3II expression was activated after CoCl2 treatment in the presence of NH4Cl (lane 4) while lutein was
able to attenuate this LC3II accumulation (lane 5). (B) Representative fluorescence microscopy images
showed an increased number of LC3 punctate cells in CoCl2 and NH4Cl co-treated cells. Administration of
lutein alleviated the puncate cells upon CoCl2 treatment. (C) Quantification of number of LC3 puncate cells.
Data was presented as the percentage of LC3 puncate cells over the total number of cells counted. n = 5 in
each group. *P< 0.05, ***P<0.001 versus normal control group; ##P< 0.01 versus NH4Cl and CoCl2 co-
treatment group; #P< 0.05, versus vehicle-treated group. Scale bar, 50 μm.
doi:10.1371/journal.pone.0167828.g006
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triggered autophagy in rat cardiomyoblasts (H9c2) and retinal ganglion cells (RGC-5) cell line
[22,42]. A study reported that the anti-apoptotic protein Bcl-2 acts as a pro-survival protein
and negatively regulates autophagy, indicating the crosstalk between apoptosis and autophagy
[43]. Here, we also showed that CoCl2 induce not only apoptosis but also autophagy in rMC-1
cells. Inhibition of autophagy using a pharmacological approach with 3-MA prevented the loss
of viability against CoCl2-induced hypoxic injury, suggesting that the autophagic event con-
tributed to CoCl2-induced cell death. Our findings also revealed that protein level of Bcl-2 was
suppressed by CoCl2 treatment but its expression was enhanced in lutein-treated cells,
Fig 7. Anti-autophagic property of lutein was involved in mTOR-mediated autophagy pathway. (A) Western
blotting and the densitometric analysis showed that the phosphorylated AMPK was up-regulated in CoCl2-treated
cells. (B-D) Protein levels of mTOR-associated proteins including P-mTOR, P-p70S6K and P-ULK1 (Ser757) were
measured by Western blotting (normalized by β-actin) and quantified by densitometry. 20μM of lutein was able to
restore the phosphorylation levels of P-mTOR and P-p70S6K upon CoCl2-induced hypoxia. (E) Rapamycin was used
to induce autophagy and chloroquine was also added to block the formation of autolysosome upon rapamycin-
mediated autophagy. Densitometry analysis showed that LC3II protein expression was up-regulated in rapamycin-
induced autophagy and accumulated in the presence of chloroquine (lane 6). Lutein treatment was able to decrease
LC3II expression in rMC-1 cells upon rapamycin and chloroquine co-treatment (lane 7). n = 5 in each group. *P< 0.05,
**P<0.01, ***P<0.001 versus normal control group; #P< 0.05, ##P<0.01 versus Lutein-treated group; #P< 0.05,
rapamycin and chloroquine co-treatment group.
doi:10.1371/journal.pone.0167828.g007
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suggesting that restoration of the pro-survival protein Bcl-2 might partly contribute to the pro-
tective effects of lutein against both apoptosis and autophagy. In addition, expression of lipi-
dated form LC3II and autophagic vacuoles was attenuated in lutein-treated rMC-1 cells,
suggesting that lutein might be involved in alleviation of autophagy provided that LC3II abun-
dance is associated with formation of autophagosomes [27]. Moreover, accumulation of LC3
punctate cells were diminished in lutein-treated groups, further depicting our findings that
lutein reduced autophagosome formation through reducing the autophagic flux.
It is known that mTOR is an important regulator for cell growth and metabolism; disrup-
tion of mTOR activity might contribute to cell death [44]. More importantly, mTOR nega-
tively regulates autophagy through the phosphorylation of ULK1 (Ser 757), preventing the
formation of ULK complex and subsequently inhibit autophagosome formation [28,45].
AMPK is an essential energy sensor that helps to maintain cellular homeostasis and it nega-
tively regulates mTOR hence induces autophagy [28]. Our findings clearly showed that phos-
phorylated form of AMPK was up-regulated in CoCl2-treated rMC-1 cells while
phosphorylation of mTOR and its substrate p70S6K was inhibited, suggesting that abrogation
of mTOR activity is associated with CoCl2-induced autophagy. Phosphorylation of ULK1 (Ser
757) was also suppressed upon CoCl2 treatment, indicating that CoCl2 triggers autophagy by
inhibition of mTOR pathway and de-phosphorylation of ULK1. Lutein administration
restored the phosphorylation of mTOR and p70S6K, indicating that reactivation of mTOR
pathway may be associated with lutein-mediated anti-autophagic protection. Rapamycin is
commonly used as the inhibitor of mTOR pathway and it suppresses the inhibitory function of
mTOR, leading to the formation of ULK complex and activates autophagy. Here, rapamycin
treatment triggered LC3II expression in rMC-1 cells and the autophagosome-associated LC3II
further accumulated after impairment of lysosomal degradation by chloroquine, indicated by
the increased number of green fluorescence-labeled autophagic vesicles. We further found that
lutein effectively attenuated the protein expression of LC3II in rapamycin and chloroquine co-
treated cells, suggesting that lutein is involved in mTOR-associated autophagy.
We together with others have reported the anti-apoptotic, anti-oxidative and anti-inflam-
matory effects of lutein in various in vivo and in vitro models of retinal diseases [16,21,46–49].
Here, we further strengthened the anti-apoptotic effects of lutein and its possible mechanistic
pathway on protecting retinal cells using a chemical induced hypoxic cell model. Lutein there-
fore may be beneficial in eye diseases where apoptotic cell death has been reported such as
glaucoma, diabetic retinopathy and retinopathy of prematurity [50–52]. Most importantly, we
discovered a novel protective effect of lutein in preventing autophagosome formation upon
hypoxia-induced autophagy. Suppression on the flux of autophagosome formation can thus
protect the retinal cells from hypoxic damage. In fact, modulation of autophagy become a ther-
apeutics target for treatment of ocular diseases such as glaucoma, diabetic retinopathy and
age-related macular degeneration (AMD) [4,53,54] however, the safety and side effects of the
anti-autophagic drug has been concerned [55]. Developments of novel anti-autophagic drugs
that are more specific to autophagic pathway and clinically safer are emerged. Several studies
documented that mTOR can be the therapeutic target in various ischemic diseases [56–58]. A
recent proteomics study reported that mTOR pathway was suppressed after retinal I/R injury,
further delineating the protective role of mTOR [59]. It has been reported that increasing
mTOR phosphorylation was neuroprotective against ischemic brain injury [58] and this
prompt us to speculate that lutein not only protects the retinal Műller cells from hypoxia-
induced apoptosis but also autophagy, possibly by targeting mTOR-associated pathway and
improving cell survival against hypoxic injury.
Műller cells are the major glial cell type in the retina, it maintains homeostasis and protects
retinal ganglion cells from neurotoxicity [60]. Our previous studies using retinal ischemic
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animal model demonstrated that lutein protected retinal neuronal cell death as well as Műller
cell gliosis [1,21]. Together with our earlier studies [1,19,21], the present study prompt us to
speculate that lutein protects ganglion cell loss possibly through attenuating apoptosis and
autophagy in glial cell. Taken together, lutein has been shown to be safe as a daily supplement
for ocular health with minimal side effects, its therapeutic potential as a clinically safe-to-be
used protectant is strongly indicated.
Supporting Information
S1 Fig. Autophagy was involved in CoCl2-induced cell death in rMC-1 cells. Percentage of
cell viability. 3-MA-pretreated rMC-1 cells showed higher viability when compared with the
vehicle-treated group after CoCl2 for 24 hours. Treatment of 3-MA only without hypoxia did
not affect the viability when compared with the normal control. n = 5 in each group.

P<0.001 versus normal control group; #P< 0.05 versus vehicle-treated group.
(TIF)
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